Transfection of Sertoli cells with androgen receptor alters gene expression without androgen stimulation by Fietz, Daniela et al.
Fietz et al. BMC Molecular Biol  (2015) 16:23 
DOI 10.1186/s12867-015-0051-7
RESEARCH ARTICLE
Transfection of Sertoli cells 
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Abstract 
Background: Androgens play an important role for the development of male fertility and gained interest as growth 
and survival factors for certain types of cancer. Androgens act via the androgen receptor (AR/Ar), which is involved in 
various cell biological processes such as sex differentiation. To study the functional mechanisms of androgen action, 
cell culture systems and AR-transfected cell lines are needed. Transfection of AR into cell lines and subsequent gene 
expression analysis after androgen treatment is well established to investigate the molecular biology of target cells. 
However, it remains unclear how the transfection with AR itself can modulate the gene expression even without 
androgen stimulation. Therefore, we transfected Ar-deficient rat Sertoli cells 93RS2 by electroporation using a full 
length human AR.
Results: Transfection success was confirmed by Western Blotting, immunofluorescence and RT-PCR. AR transfection-
related gene expression alterations were detected with microarray-based genome-wide expression profiling of trans-
fected and non-transfected 93RS2 cells without androgen stimulation. Microarray analysis revealed 672 differentially 
regulated genes with 200 up- and 472 down-regulated genes. These genes could be assigned to four major biological 
categories (development, hormone response, immune response and metabolism). Microarray results were confirmed 
by quantitative RT-PCR analysis for 22 candidate genes.
Conclusion: We conclude from our data, that the transfection of Ar-deficient Sertoli cells with AR has a measurable 
effect on gene expression even without androgen stimulation and cause Sertoli cell damage. Studies using AR-
transfected cells, subsequently stimulated, should consider alterations in AR-dependent gene expression as off-target 
effects of the AR transfection itself.
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Background
Androgens play a pivotal role for the development of the 
male phenotype, the initiation and maintenance of sper-
matogenesis and therefore male fertility (for review see 
[1]). The action of the most important androgens testos-
terone (T) and dihydrotestosterone (DHT) is mediated 
by the androgen receptor (AR/Ar). It is a ligand-activated 
transcriptional factor belonging to the nuclear recep-
tor superfamily. The AR/Ar gene is located on the X 
chromosome and consists of eight exons, coding for the 
N-terminal transcription regulation domain, the DNA 
binding domain (DBD) in the middle of the protein and 
the C-terminal ligand binding domain (LBD). The DBD 
as well as the LBD are highly conserved throughout spe-
cies (for review see [2]). Bound to its ligand, the andro-
gen-AR complex is translocated into the nucleus, binds 
to the DNA (androgen responsive elements, AREs) and is 
able to activate or repress gene expression by recruiting 
co-activators or co-repressors (for review see [3]). The 
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activity of steroid hormone receptors is also regulated by 
post-transcriptional modifications. In case of AR/Ar, a 
great variety of these modifications has been described, 
i.e. phosphorylation, acetylation, ubiquitination and also 
methylation (for review see [4]).
The AR/Ar is expressed in all tissues except the 
spleen (for review see [2]). In the testis, it is expressed 
in interstitial Leydig cells and endothelial cells, as well 
as in peritubular myoid cells and tubular Sertoli cells 
[5], for review see [1]. Since germ cells do not express 
AR/Ar, the androgen action has to be mediated towards 
the germ cells by Sertoli cells. These somatic cells have 
been described as branched cells surrounding all germ 
cell stages [6, 7]. As was shown by Willems et  al. [8], a 
selective ablation of Ar in mouse Sertoli cells (SCARKO) 
leads to a disturbed Sertoli cell maturation including a 
delayed and defective establishment of the blood-testis 
barrier. Moreover, no meiotic germ cells were observed 
in SCARKO mice, showing the importance of a func-
tional AR/Ar on Sertoli cell biology and for the develop-
ment of germ cells.
To examine the role of the AR/Ar in different biologi-
cal processes such as cell growth and survival as well as 
AR/Ar-dependent gene expression, cell culture systems 
are needed. Therefore, administration of T and/or the 
more efficient metabolite DHT has widely been used to 
investigate the effect of androgens and AR/Ar, respec-
tively, in diverse cultured cells such as human breast can-
cer cells, adrenocortical carcinoma cells, murine skeletal 
muscle cells or liver carcinoma cells [9–12]. Addition-
ally, AR/Ar-deficient cell lines were used, e.g. AR-defi-
cient MCF-7 breast cancer cells, to examine the effect 
on estrogen administration in a system lacking AR [13]. 
Szelei et  al. [14] transfected AR-deficient MCF-7 breast 
cancer cells with human AR and showed an inhibition 
of proliferation. Also prostate cancer cells devoid of AR 
were transfected with human AR and showed a decreased 
proliferation rate [15]. The question is, whether the trans-
fection procedure itself might have led to an altered 
expression of AR/Ar-dependent and AR/Ar-independent 
genes. Xiao et  al. [16] demonstrated equal concerns in 
Amh-Cre-transfected mouse, where an increase of oxi-
dative stress and lipid peroxidation in Sertoli cells was 
detected even without stimulation.
Beside “classical” androgen-dependent prostate can-
cer development, also androgen-independent signalling 
pathways gained increasing interest as shown recently by 
Li et al. [17]. The authors describe a persistent transcrip-
tional activity in castration-resistant prostate cancer cell 
lines in the absence of androgens. This transcriptional 
activity was mediated by a truncated AR protein lacking 
the LBD. This raises the question, whether an androgen-
independent AR/Ar action is always important in cell 
biology and which genes might be expressed or repressed 
by AR/Ar presence alone.
For this purpose, we transfected rat Sertoli cells which 
have been shown to be deficient of Ar with full length 
human AR DNA. After transfection, we performed 
genome-wide microarray analysis and compared the 
gene expression pattern with non-transfected Sertoli 
cells to identify a possible “intrinsic” activity of AR/Ar 
without androgen administration. We found signifi-
cantly altered gene expression in transfected compared 
with non-transfected cells, possibly influencing Sertoli 
cell function.
Results
Transfection of 93RS2 cells with the human AR
Performing RT-PCR with primers specific for mouse and 
rat Ar, respectively, rat Sertoli cells (93RS2, [18]) proved 
to lack endogenous Ar (Fig. 1) and were therefore chosen 
for further experiments.
Success of transfection with full length human AR 
CDS was validated by immunofluorescence (IF, Fig. 2a), 
Western Blot (Fig.  2b) and RT-PCR (Fig.  2c). As the 
commercially available human AR was introduced in a 
GFP-coupled vector system, we used a rabbit anti-GFP 
antibody for IF experiments in transfected cells whereas 
non-transfected cells were used as internal negative con-
trol. Using PAGE, we were able to show the CAG repeat 
length of 17 to be stable throughout different settings 
(Fig. 2d).
Microarray analysis revealed an altered gene expression 
in transfected 93RS2 cells
Microarray analysis revealed 672 significantly regulated 
genes (p < 0.01 and fold change (FC) >2.0). Of these, 200 
Fig. 1 Expression of androgen receptor (Ar) mRNA in Sertoli cell 
cultures. To find an appropriate cell culture system for our planned 
transfection studies, RT-PCR with specific primers for mouse and rat 
Ar was performed. Testis homogenate from rat and mouse served 
as positive control, whereas water was used as no template control 
(NTC) samples. We tested two mouse (WL3 and SK-11) as well as two 
rat Sertoli cell lines (SCIT-C8 and 93RS2). The latter revealed no expres-
sion of intrinsic Ar and were therefore used for further experiments
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genes showed higher gene expression values, whereas 
472 revealed a lower gene expression in 93RShAR17 cells 
compared with non-transfected cells.
Hierarchical clustering of the 672 significantly regu-
lated genes shows two clusters clearly differentiating 
between transfected and non-transfected cells (Fig.  3). 
Three biological replicates have been tested and show a 
homogeneous expression pattern, indicating high repro-
ducibility of microarray results. An overview of the ten 
highest regulated genes for down- and up-regulation is 
given in Table 1. Complete array data may be found fol-
lowing the link provided [19].
“Development”, “Hormone response” and “Immune 
response” are the predominant functions of the differently 
regulated genes
Of 370 annotated down-regulated genes, 330 could be 
assigned to DAVID functional categories, and 124 out of 
142 annotated up-regulated genes, respectively.
An overview of the functional categories that have been 
inferred with DAVID is given in Table 2. Down-regulation is 
predominant in “Cell development/Cell contact”, “Response 
to hormone stimulus” and “Nucleotide catabolic pro-
cess”, whereas regulation is evenly distributed in “Immune 
response”. The highest score values are achieved by four 
Fig. 2 Transfection control of 93RS2 Sertoli cells. a 24 h after transfection, transfected (a) and non-transfected (b) cells as negative control were 
fixed for IF experiments. left Incubation with rabbit anti-GFP antibody showed successful transfection of almost 80 % of cells. right No staining signal 
was detectable in non-transfected cells. Scale bars in main image: 200 µm, detail: 25 µm. DAPI counterstain. b Western Blot analysis revealed AR pro-
tein in transfected Sertoli cells at approx. 135 kDa (1) and in human testis tissue at the expected molecular weight of 110 kDa (2). The higher protein 
weight measured in transfected cells is due to coupling of AR with GFP. c Expression of human AR mRNA was tested in human testis homogen-
ate (1), transfected (2) and non-transfected cells (3). AR mRNA was detected in the positive control and transfected 93RS2hAR17 cells, but not in 
non-transfected cells and the NTC (lane 4). d To control the CAG repeat length in transfected 93RS2 cells, we performed high-resolution PAGE. Three 
different passages of 93RShAR17 cells (lanes 1–3) were analysed and revealed a band for human AR at 185 bp by using two different DNA ladders. 
By sequencing, 185 bp was shown to be typical for the presence of 17 CAG repeats. Lane 4 no template control (NTC)
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significantly overrepresented gene ontology (GO) categories 
clustered under “Biological adhesion”, whereas the highest 
number of genes is assigned to 15 GO categories grouped 
as a cluster named “Epithelium development”. More than 
half of the functional assigned groups belong to cell devel-
opment and cell contact while 25  % of the functionally 
assigned genes are related to immune response. 36 genes 
can be attributed to “Hormone stimulus” and a minority of 
12 genes contributes to “Nucleotide catabolic process”.
Upstream regulation analysis identified more activation 
than de‑activation
Upstream regulation analysis with IPA is based on 
gene expression patterns and predicts activation or 
deactivation of regulators of the differentially regulated 
genes. The results show that more upstream regulators 
are predicted to be activated (n  =  51) than inhibited 
(n = 20).
These predictions are based on 220 genes from which 
95 contributed to activation as well as to deactivation. 
The proportion of overall down- and up-regulation is 
mirrored in these genes with more down-regulation in 
inhibition as well as in activation (Tables 3, 4, 5, 6). The 
majority of deactivated upstream regulators (8 out of 20) 
are classified as transcription regulators. Activation is 
mainly predicted for cytokines (14 out of 51).
Validation of microarray data by RT‑qPCR
For validation of microarray results we performed RT-
qPCR for 22 candidate genes, showing different ranges 
of regulation (up, down). Among the chosen genes, some 
are mainly associated with development and are known 
Sertoli cell markers, such as Dhh [20], Gja1 [21], Inhbb 
[22], and Tf [23]. Other genes are markers for differentia-
tion and proliferation (e.g. Bambi and Tgfb1i1 [24]) and 
some are involved in apoptosis, such as Myc and Tnfrsf1a 
[25]. Results from RT-qPCR were mostly consistent with 
data from microarray analysis (Fig.  4). Relative gene 
expression was lower in transfected compared to non-
transfected Sertoli cells in 13 of 22 cases. Gene expres-
sion of Cdkn1a, Egr1, Fst, Gja1, Myc, Pmepa1, Ptsg2, Rarg 
and Tnfrsf1a was higher in 93RShAR17 cells compared 
to Ar-deficient 93RS2 cells. In the latter case, it has to be 
mentioned, that differences of the means did not reach 
significance in four genes, due to high variability of Cq.
Discussion
To study the effects of androgens and AR/Ar on diverse 
cell culture systems and the relevance for cell biology, 
cell culture experiments were conducted in different 
human cell lines (e.g. breast cancer cells, adrenocorti-
cal carcinoma cells, murine skeletal muscle cells or liver 
carcinoma cells [9–12]). Also AR-deficient cell lines have 
been used, either transfected with AR [14, 15] or with-
out [13]. Both groups working with transfected cell lines 
performed their experiments using either not stimulated 
[14] or mock-transfected cells [15] as negative controls. 
Moreover, Jacobsen et  al. [26] showed, that transfection 
of MCF-7 breast cancer cells lead to severe differences 
in gene expression levels in distinct genes, depending on 
the transfection reagent used. Interestingly, transfection 
with a vector encoding for a reporter gene and a vector 
without insert, respectively, revealed no differences in 
gene expression. This implies, that the transfection pro-
cedure itself might alter gene expression in these cells. 
Therefore, we performed gene expression analysis with 
AR-transfected rat Sertoli cells using non-transfected 
Fig. 3 Hierarchical clustering of 672 significantly altered genes. Genes 
are depicted in rows and samples in columns. Blue indicates down-
regulation whereas red shows upregulation. Clustering was done 
using “Pearson correlation” and “complete linkage”. The tree on the left 
reflects the distances between gene profiles based on this algorithm
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cells as controls to show “intrinsic” gene expression 
alterations due to the transfection procedure. As elec-
troporation has been shown to be superior with respect 
to cell viability and also transfection efficiency compared 
to chemical transfection using lipofectamine [27], we 
applied this technique to introduce the AR. Cell viability 
was not influenced by electroporation, but whole genome 
microarray analysis showed an altered gene expression. 
Surprisingly, more genes have been down-regulated than 
up-regulated comparing transfected and non-transfected 
cells. We selected 22 genes showing an altered expression 
pattern and confirmed microarray results with RT-qPCR 
analysis. In the following, we will discuss in more depth 
interesting genes and pathways, respectively.
Among the down-regulated genes, many are involved 
in metabolic processes, as for example in iron trans-
port and metabolism (cytochrome b reductase 1 
(Cybrd1), FC  =  −107; transferrin (Tf), FC  =  −6,898; 
Table 2 Overview of functional gene ontology categories according to their pattern of significantly regulated genes
Numbers in normal brackets denote the number of grouped GO categories. Absolute numbers of regulated genes per main group are given in squared brackets, 
examples of regulated genes are shown for up- and down-regulated genes
H hormone stimulus, N Nucleotide Catabolic Process
Group Cluster# Cluster of GO categories Score Symbols
Cell development/cell contact [106] 1 Biological adhesion (4) [25] 2.27 Up Vnn1, Amigo2, Bcam, Cdh2, Ceacam1, 
Col12a1, Col14a1, Col16a1, Dsg2, Gpc1, 
Mcam, Omd, Sned1, Col18a1, Ctgf, Gpr56, 
Ncam1, Igfbp7
Down Itgb8, F5, Pcdh1, Pcdh18, Plcxd2, Ptprm, Ctgf
3 Axonogenesis (13) [36] 1.89 Up Aldh1a2, Apbb1, Apoe, Boc, Cd24, Cdkn1c, 
Chn2, Col18a1, Col18a1, Cxcl12, Efna2, 
Efnb1, Fgfr2, Gli2, Gpc2, H19, Hoxc10, 
Krt19, Lpar3, Nnat, Nrep, Obsl1, Pmp22, 
Ppp1r9a, Prickle2, Sdc2, Sema4f, Shroom3, 
Sox5, Uchl1
Down Ptprm, Epha7, Dpysl3, Mtss1, Nes, Sgk1
4 Retinoid metabolic process (5) [8] 1.75 Up Akr7a3, Aldh1a2, As3mt, Ldhb, Rarres2, Rbp1
Down Crabp2, Rbp2
7 Epithelium development (15) [50] 1.47 Up Acp5, Adamts1, Adck3, Aldh1a2, Celsr1, 
Col18a1, Col1a1, Col4a1, Cxcl12, Disp1, 
Efna2, Efnb1, Fbn1, Fgfr2, Foxe1, Foxl2, Gli2, 
H19, Hmx2, Hoxc10, Irf6, Kazn, Mgp, Mn1, 
Mycn, Pgf, Plce1, Serpinf1, Sfrp2, Shroom3, 
Sox5, Spry1, Srgn, Tbx18, Tbx4, Tek, Tgfb1i1, 
Tgm2, Upk1b
Down Ctgf, Crabp2, Fst, Ptger2, Rsad2, Cdx2, Hoxb6, 
Krt14, Ptgs2, Foxp2, Myc
H [36] 2 Response to steroid hormone stimulus 
(10) [36]
1.90 Up Acp5, Adamts1, Adck3, Aldh1a2, Apoe, Boc, 
Cd24, Celsr1, Col1a1, Cxcl12, Disp1, Efna2, 
Efnb1, Fgfr2, Gli2, Gpr56, H19, Igfbp7, Krt19, 
Lpar3, Mgp, Ncam1, Nnat, Pgf, Plce1, Sdc2, 
Serpinf1, Sfrp2, Tek, Tgfb1i1, Tgm2
Down Foxp2, Myc, Nes, Ptgs2, Sgk1
Immune response [55] 5 Innate immune response (4) [34] 1.69 Up Acp5, Adck3, Afap1l2, Apbb1, C2, Cd24, 
Cxcl12, Cyp4f6, Il27ra, Masp1, Ptpn6, RT1-
DMb, Tf, Tgm2, Tinagl1, Tlr2, Vnn1, Zfr2
Down A2 m, C3ar1, Ccl2, Ccl4, Ereg, F2rl1, Gch1, 
Il1rl1, Irf7, Irgm, Nppb, Oas1b, Oasl2, Prg4, 
Ptgs2, Rsad2
8 Cell surface receptor linked signal trans-
duction (3) [25]
1.35 Up Adamts1, Adck3, Apoe, Boc, Cd24, Celsr1, 
Cxcl12, Disp1, Efna2, Efnb1, Fgfr2, Gli2, 
Gpr56, Lpar3, Ncam1, Plce1, Sfrp2, Tek, 
Tgfb1i1, Tgm2
Down Ctgf, Epha7, Fst, Itgb8, Ptger2
N [12] 6 Nucleotide catabolic process (7) [12] 1.47 Up Akr7a3, Ampd3, Gucy1b3, Nt5e, Nudt7, 
Pde4a, Pde4b, Prodh
Down Gch1, Nppb, Ppat, Upp1
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six-transmembrane epithelial antigen of the prostate 2 
(Steap2), FC = −2.3). Iron is relevant for Sertoli cells in 
two different aspects: as supervisors of germ cell develop-
ment, Sertoli cells provide iron which is needed for DNA 
synthesis and cell growth of germ cells that undergo mul-
tiple mitotic divisions [28]. On the other hand, Sertoli 
cells avoid toxic environmental conditions that might 
be given at elevated concentrations of insoluble ferric 
iron (Fe3+). Therefore, Sertoli cells secrete transferrin, 
the product of the Tf gene [29], which may be used as a 
marker for Sertoli cell function and differentiation [23] as 
it creates an environment low in free iron that impedes 
bacterial survival in a process called iron withholding. 
The protein level of Tf decreases in inflammation. The 
lower expression of Tf gene, which was confirmed in RT-
qPCR (Fig. 4), could be interpreted as a sign of severe dis-
turbance and inflammation of cells.
The latter is reflected by the high proportion of 
upstream regulators related to immune response 
(=  cytokines and members of the MAP kinase sig-
nalling pathway) that are predicted to be activated 
(Table  3) and the presence of multiple immune 
response-related genes on top of the list in up-reg-
ulation (Table  1). “Immune response” is the second 
huge cluster of altered genes in our study, represented 
by e.g. prostaglandin-endoperoxidase synthase 2 
(Ptgs2, FC  =  3.558) also known as cyclooxygenase 2 
(Cox2). An increase in Cox2 expression was observed 
by Matzkin et  al. [30] in Leydig cells of infertile men 
showing either hypospermatogenesis, Sertoli cell only 
syndrome or maturational arrest. By increased num-
bers of testicular macrophages, levels of interleukin 
1β (Il-1β) are increased and activates Ptgs2, the key 
enzyme in prostaglandin synthesis culminating in 
inflammation. The expression of Tf, Ptgs2 and inter-
leukins is coupled in Sertoli cells; as shown by Yama-
guchi et  al. [31], incubation with cisplatin lead to an 
increase in Ptgs2 and a decrease in Tf expression in 
Sertoli cell cultures, similar to our study. Additionally, 
an analysis of upstream regulation using IPA revealed 
a high number of key players in inflammation to be 
activated showing congruently high FCs for Ccl5, Irf7, 
and Ifnb1. This might on the one side be due to the 
transfection procedure itself and/or reflect inflamma-
tory processes in the cells due to increased cell dam-
age. Remarkably, an influence of molecular biological 
techniques on gene expression and immune response 
has been observed also in regard to short-interfering 
RNAs (siRNAs). Sledz et  al. reported an induction of 
interferon β levels in a human glioblastoma cell line 
which was transfected with siRNAs as a non-specific 
side effect additionally to the silencing of the target 
gene lamin [32] .
Table 3 Upstream regulator analysis with  IPA: types 
of predicted upstream regulators
Summarizing the regulator according to their type revealed a high proportion of 
possibly activated cytokines, whereas transcription regulators play a major role 
in inhibition
Based on gene expression patterns, predictions are made on activation or 
inactivation of known upstream regulators. Absolute activation z-scores of 
higher than 2.0 are considered to be highly significant. We found more than 
twice as much regulators predicted to be activated as compared to inhibited. 
These tables show the predicted upstream regulators with an absolute z-score 
above 2.0 in detail—some are in fact complexes or groups. The prediction is 
opposed to the real measurement on the micro array (rightmost columns), 
as far as the respective genes have passed QC and is otherwise marked as 
“not measured”. Mean expression per group is given as logarithm of the 
intensity to base 2. Reasonably high expression values are in bold face. The 
column “regulation AR17” denotes if the respective gene is contained in the 
set of regulated genes (level = L1) or at least close to significance (level = L2/
L3) which holds true for the minority of genes. Activation or inhibition is not 
necessarily reflected by significant change of gene expression, since processes 
not measurable on a micro array, like for example phosphorylation, are more 
likely to be responsible for that
Activation (n = 51) Inhibition (n = 20)
Cytokines/group of cytokines 14 Transcription regulator 8
Others/complex of others 8 Cytokine 2
Kinases, group of kinases 8 Enzyme 2
Growth factors/complex of 
growth factors
6 Other 2
Transcription regulator 6 G-protein coupled receptor 1
Transmembrene receptors 4 Growth factor 1
Enzymes 3 Ligand-dependent nuclear 
receptor
1
Ligand-dependent nuclear 
receptor
1 Peptidase 1
Peptidase 1 Phosphatase 1
Transporter 1
Table 4 Upstream regulator analysis with  IPA: proportion 
of up- and downregulated genes
The gene expression patterns upon which the prediction is made is constituted 
by both up-regulated and down-regulated genes. The predicted activation and 
inhibition is either based on two third down regulated (n = 114/n = 78) and 
one third upregulated genes (n = 73/n = 50). 50 downregulated genes and 45 
upregulated genes contribute likewise to activation and inhibition (The details 
of the contributing gens are not shown here)
Based on gene expression patterns, predictions are made on activation or 
inactivation of known upstream regulators. Absolute activation z-scores of higher 
than 2.0 are considered to be highly significant. We found more than twice as 
much regulators predicted to be activated as compared to inhibited. These tables 
show the predicted upstream regulators with an absolute z-score above 2.0 in 
detail—some are in fact complexes or groups. The prediction is opposed to the 
real measurement on the micro array (rightmost columns), as far as the respective 
genes have passed QC and is otherwise marked as “not measured”. Mean 
expression per group is given as logarithm of the intensity to base 2. Reasonably 
high expression values are in bold face. The column “regulation AR17” denotes 
if the respective gene is contained in the set of regulated genes (level = L1) or 
at least close to significance (level = L2/L3) which holds true for the minority of 
genes. Activation or inhibition is not necessarily reflected by significant change 
of gene expression, since processes not measurable on a micro array, like for 
example phosphorylation, are more likely to be responsible for that
Gene pattern Activation only Inhibition only Both
Down regulation 64 28 50
Up regulation 28 5 45
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Table 5 Upstream regulator analysis with IPA: predicted activated regulators
IPA–prediction Micro array analysis
Upstream regulator Molecule type z‑score FDR FC Mean AR17 Mean noAR Regulation AR17 [level]
Ahr Ligand-dependent nuclear receptor 3.185 0.895 −1.017 −1.219 −1.194
Bmp6 Growth factor 2.791 0.011 −1.483 2.595 3.164
Ccl5 Cytokine 2.190 0.016 2.529 2.922 1.583 [Up L3]
Ddx58 Enzyme 2.789 0.019 2.096 3.316 2.249 [Up L3]
Dock8 Other 2.530 0.010 −1.656 2.545 3.272 [Down L2]
Egf Growth factor 2.539 <not measured>
Erk: Group of kinases (n=7) 2.372 <group>
Mapk1 Kinase 0.009 −1.019 3.670 3.697
Mapk3 Kinase 0.027 −1.280 5.646 6.002
Mapk4 Kinase 0.701 1.086 −2.321 −2.440
Mapk6 Kinase 0.037 1.131 5.152 4.975
Mapk7 Kinase 0.758 −1.047 2.862 2.928
Mapk12 Kinase 0.018 −2.005 0.121 1.125 [Down L3]
Mapk15 Kinase 0.208 1.217 0.507 0.224
Mek: Group of kinases (n=7) 2.942 <group>
Map2k1 Kinase 0.105 1.182 4.651 4.410
Map2k2 Kinase 0.177 1.090 4.816 4.691
Map2k3 Kinase −1.066 −0.092 4.360 4.452
Map2k4 Kinase 1.023 0.032 3.336 3.303
Map2k5 Kinase −1.058 −0.082 3.327 3.408
Map2k6 Kinase 1.177 0.235 3.760 3.525
Map2k7 Kinase −1.125 −0.170 −1.445 −1.275
P38 Mapk: Group of kinases (n= 5) 2.624 <group>
Mapk1 Kinase 0.009 −1.019 3.670 3.697
Mapk11 Kinase 0.087 −1.343 0.139 0.565
Mapk12 Kinase <see above>
Mapk13 Kinase <not measured>
Mapk14 Kinase 0.046 −1.276 3.242 3.594
Mapk2/1: group of Kinases (n= 2) 2.401 <group>
Map2k1 Kinase <see above>
Map2k2 Kinase <see above>
F7 Peptidase 2.592 <not measured>
Fgf2 Growth factor 2.085 0.122 1.178 0.417 0.180
Fos Transcription regulator 2.086 0.069 −1.425 2.972 3.482
Hras Enzyme 3.258 <not measured>
Ifn / Ifn alpha: Group of groups
Ifn: Group of cytokines 2.429 <group>
Ifn alpha: Group of cytokines 2.228 <group>
Ifna1 Cytokine 0.104 1.306 2.728 2.343
Ifna2 Cytokine 2.448 <not measured>
Ifna4 Cytokine 2.236 <not measured>
Ifna5 - 8 cyTokine (n=4) <not measured>
Ifna10, 13, 14, 16, 17, 21 Cytokine (n=6) <not measured>
Ifnk Cytokine <not measured>
Ifnw1 Cytokine <not measured>
Ifnz Cytokine <not measured>
Ifn beta: Group of cytokines (n=2) 2.767
Ifnb1 Cytokine 2.591 0.079 2.953 −1.949 −3.511
Il6 Cytokine 2.443 0.014 1.481 −0.730 −1.296
Ifnar: Group of transmembrane receptors 2.749 <group>
Ifnar1 Transmembrane receptor <not measured>
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Table 5 continued
IPA–prediction Micro array analysis
Upstream regulator Molecule type z‑score FDR FC Mean AR17 Mean noAR Regulation AR17 [level]
Ifnar2 Transmembrane receptor <not measured>
Ifne Cytokine 2.219  <not measured>
Ifng Cytokine 2.811 <not measured>
Ifnl1 Cytokine 2.764 <not measured>
Igf2 Growth factor 2.213 0.001 −9.285 1.909 5.124 [Down L1]
Ikbke Kinase 2.090 0.013 −2.034 −1.262 −0.238 [Down L3]
Il1: group of Cytokines (n=11) 2.207
Il1b Cytokine <not measured>
Il18 Cytokine 2.372 0.300 −1.056 0.531 0.610
Il1f10 Cytokine 0.689 1.102 −2.284 −2.424
Il1rn Cytokine 0.009 1.812 0.062 −0.796 [Up L2]
Il33 Cytokine 0.001 10.690 1.998 −1.420 [Up L1]
Il17a Cytokine <not measured>
Il36a Cytokine <not measured>
Il36b Cytokine <not measured>
Il36g Cytokine <not measured>
Il36rn Cytokine 0.019 1.393 2.076 1.598
Il37 Cytokine <not measured>
Irf3 Transcription regulator 3.157 0.520 1.336 3.450 3.033
Irf5 Transcription regulator 2.934 0.113 1.096 1.321 1.188
Irf7 Transcription regulator 3.901 0.003 5.540 5.574 3.104 [Up L1]
Kras Enzyme 2.616 0.191 −1.097 3.119 3.253
Lh [Cga, Lhb] Complex 2.012
Lhb Other 0.480 1.044 2.593 2.530
Cga Other 0.251 1.273 −0.193 −0.541
Map3k7 Kinase 2.375 0.352 −1.067 4.577 4.671
Mavs Other 2.630 0.021 −1.231 2.569 2.868
Pdgf bb Complex 3.491 <group>
Pdgfb Growth factor 1.156 2.037 1.828
Pdlim2 Other 2.324 0.003 1.346 3.226 2.798
Samsn1 Other 2.309 <not measured>
Sash1 Other 2.530 <not measured>
Sphk1 Kinase 2.172 0.611 1.237 −0.033 −0.341
Src Kinase 2.158 0.033 1.348 3.704 3.273
Stat1 Transcription regulator 2.194 0.013 1.375 3.163 2.703
Stat2 Transcription regulator 2.173 0.535 1.067 3.865 3.772
Tac1 Other 2.153 0.910 1.055 −2.385 −2.462
Tgfa Growth factor 2.165 0.586 1.088 2.152 2.031
Ticam1 Other 2.702 0.574 −1.035 3.646 3.696
Tlr3 Transmembrane receptor 3.633 0.049 −1.414 −0.244 0.256
Tlr4 Transmembrane receptor 3.175 <not measured>
Tlr9 Transmembrane receptor 3.645 0.249 1.134 2.534 2.353
Tnfsf11 Cytokine 2.168 0.539 1.115 −0.643 −0.800
Z-score < 2.0
Based on gene expression patterns, predictions are made on activation or inactivation of known upstream regulators. Absolute activation z-scores of higher than 
2.0 are considered to be highly significant. We found more than twice as much regulators predicted to be activated as compared to inhibited. These tables show the 
predicted upstream regulators with an absolute z-score above 2.0 in detail—some are in fact complexes or groups. The prediction is opposed to the real measurement 
on the micro array (rightmost columns), as far as the respective genes have passed QC and is otherwise marked as “not measured”. Mean expression per group is given 
as logarithm of the intensity to base 2. Reasonably high expression values are in bold face. The column “regulation AR17” denotes if the respective gene is contained 
in the set of regulated genes (level = L1) or at least close to significance (level = L2/L3) which holds true for the minority of genes. Activation or inhibition is not 
necessarily reflected by significant change of gene expression, since processes not measurable on a micro array, like for example phosphorylation, are more likely to 
be responsible for that
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Table 6 Upstream regulator analysis with IPA: Predicted inactivated regulators
Z-score < −2.0
Based on gene expression patterns, predictions are made on activation or inactivation of known upstream regulators. Absolute activation z-scores of higher than 2.0 are 
considered to be highly significant. We found more than twice as much regulators predicted to be activated as compared to inhibited. These tables show the predicted 
upstream regulators with an absolute z-score above 2.0 in detail—some are in fact complexes or groups. The prediction is opposed to the real measurement on the micro 
array (rightmost columns), as far as the respective genes have passed QC and is otherwise marked as “not measured”. Mean expression per group is given as logarithm 
of the intensity to base 2. Reasonably high expression values are in bold face. The column “regulation AR17” denotes if the respective gene is contained in the set of 
regulated genes (level = L1) or at least close to significance (level = L2/L3) which holds true for the minority of genes. Activation or inhibition is not necessarily reflected 
by significant change of gene expression, since processes not measurable on a micro array, like for example phosphorylation, are more likely to be responsible for that
IPA–prediction Micro array analysis
Upstream regulator Molecule type z‑score FDR FC Mean AR17 Mean noAR Regulation 
AR17 [level]
Ackr2 G-protein coupled receptor −3.162 0.061 1.308 0.389 0.001
Bcl6 Transcription regulator −2.353 0.233 1.041 1.031 0.973
Fbxo32 Enzyme −2.213 0.797 1.048 −0.588 −0.655
Gata2 Transcription regulator −2.965 0.061 −3.356 −1.682 0.065
Gdf2 Growth factor −2.400 <not measured>
Hmox1 Enzyme −2.425 0.011 1.631 3.108 2.402 [Up L3]
Htt Transcription regulator −2.828 0.560 1.033 2.380 2.334
Il10 Cytokine −2.394 <not measured>
Il1rn Cytokine −3.108 0.009 1.812 0.062 −0.796 [Up L2]
Irgm1 Other −2.236 <not measured>
Mitf Transcription regulator −2.535 0.081 −1.456 2.487 3.029
Nkx2-3 Transcription regulator −2.183 0.168 1.119 −1.622 −1.785
Pparg Ligand-dependent nuclear receptor −2.353 0.009 −1.950 −0.203 0.761 [Down L2]
Runx2 Transcription regulator −2.137 0.021 1.358 4.291 3.850
Sftpa1 Transporter −2.111 0.752 −1.087 −2.019 −1.899
Shh Peptidase −2.168 <not measured>
Socs1 Other −3.084 <not measured>
Socs3 Phosphatase −2.216 0.591 1.111 −1.131 −1.283
Sox9 Transcription regulator −2.219 <not measured>
Trim24 Transcription regulator −2.331 0.119 −1.166 2.191 2.413
Fig. 4 Quantitative RT-PCR was performed to validate microarray analysis results. Gene expression analysis for 22 genes that showed deviant 
gene expression in microarray analysis has been performed using 2−ΔΔCq method. RT-qPCR has been performed using three technical replicates 
in a double determination. Gene expression in non-transfected 93RS2 cells was used as calibrator and therefore set as “1”. Data are presented as 
mean ± SEM. (standard error of the mean) and differences in mean values have been assessed with SPSS software; *p ≤ 0.05, n.d. not detectable
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Not only metabolism and immune response gene 
expression seem to be altered in transfected Sertoli cells, 
but also cell cycle and development genes (desert hedge 
hog (Dhh) FC = −2.032; fibroblast growth factor recep-
tor 2 (Fgfr2) FC  =  −8.239; follistatin (Fst) FC  =  2.162; 
inhibin beta b (Inhbb) FC  =  −3.126). Dhh is involved 
in various areas of embryonic development, including 
testicular cord formation. It is expressed in mouse Ser-
toli cell precursors during mid- to late gestation [33] and 
also is important for germ cell development after puberty 
in mouse [34] and rat testis [35]. In the mouse, a lack of 
Dhh results in a severe impairment of spermatogenesis 
due to a lack of spermatogonial development beyond 
primary spermatocytes [34]. Fgfr2 is a known differentia-
tion factor in prenatal Sertoli cells as it is concomitantly 
expressed with Sry and is essential for subsequent expres-
sion of anti-muellerian hormone (Amh) and Sox9 [36]. 
IPA analysis of upstream regulation predicted an inhibi-
tion of transcription factor Sox9 with a z-score of −2.2 
(Table  6). Moreover, lack of Fgfr2 might cause a partial 
XY sex reversal, as loss of Fgfr2 leads to an up-regulation 
of Follistatin (Fst), a female somatic cell marker [37], 
which was confirmed by microarray and RT-qPCR. A 
down-regulation of the Sertoli cell marker Inhbb (for 
review see [38]) also points to a decreased Sertoli cell 
function and a severe disturbance of spermatogenesis in 
the rat [39]. Figure 5 shows the association of Inhbb, Fst, 
Dhh, Pmepa1, Fgfr2, Ptgs2, Tf and Myc as especially inter-
esting genes on known pathways as predicted by IPA. 
A disturbance of Sertoli cell function is also visible in 
gene expression alteration concerning the functional 
cluster “Cell adherence” or “Cell adhesion” (Fig.  6, e.g. 
collagen type IV alpha (Col4a1) FC = −12.503; gap junc-
tion protein 1 (Gja1) FC  =  −1.188). Cell adhesion and 
formation of tight junctions between Sertoli cells gener-
ating the blood-testis barrier is one of the most impor-
tant features of Sertoli cell maturation and function (for 
review see [22]) as it is a prerequisite for intact spermat-
ogenesis. Also cell-to-cell contact and communication 
seem to be disturbed in transfected cells as indicated by 
the down-regulation of Gja1, also known as connexin 43 
(for review see [20]).
Fig. 5 Illustration of eight genes and their association to known pathways in IPA. Green color denotes down-regulation, whereas red color denotes 
up-regulation
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Conclusion
Our results indicate a severe disturbance of Sertoli 
cell metabolism, function and cell biology concern-
ing immune status and generation of blood-testis bar-
rier, caused by the transfection procedure even without 
androgen stimulation of cells. The alterations in gene 
expression levels might either be related to the transfec-
tion procedure itself and/or to the insertion of human 
AR into Ar-free rat Sertoli cells. A microarray analysis 
with mock-transfected Sertoli cell line would be needed 
to distinguish both possibilities. We consider the altered 
gene expression to be caused by AR insertion, as many 
of the altered genes were identified as AR and Sertoli cell 
specific. In either case, incubation of transfected cell lines 
with testosterone or dihydrotestosterone might lead to 
false-positive or false-negative results and additionally, 
also non-genomic pathways including AR/Ar action may 
be altered by transfection procedures. Therefore, suitable 
negative controls are needed for stimulation experiments 
with T or DHT, i.e. non-transfected cells as appropriate 
negative controls. Gene expression has to be normalized 
by these non-transfected cells to avoid false-positive or 
false-negative results regarding gene regulation.
Methods
Cell lines and culture conditions, human positive control 
tissue
We determined the expression of Ar in different Sertoli 
cell lines by RT-PCR. For this study, we used four existing 
immortalized Sertoli cell lines from either mouse (WL3, 
SK-11) [40, 41] or rat testis (93RS2) [18] kindly provided 
by our collaborators. Additionally, SCIT-C8 cells were 
generated from immortalized Sertoli cells from rat testis 
as described by Konrad et  al. [42]. We did not conduct 
Fig. 6 Hierarchical clustering of significantly regulated genes involved in cell adhesion. Clustering was done using “Pearson correlation” and 
“complete linkage”. The tree on the left reflects the distances between gene profiles based on this algorithm. AJ actin/intermediate = adherents 
junctions based on actin or intermediate filaments, TJ = tight junctions. Low significance: 1.5 < FC < 2.0 and/or FDR 0.01–0.05 High significance: 
FC > 2.0 and FDR < 0.01
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any animal research in our study and therefore eth-
ics approval was not required. Total RNA of these cells 
was isolated by peqGold Total RNA Kit (Peqlab, Erlan-
gen, Germany), set to a concentration of 200  ng/µl and 
genomic DNA was digested by RNase-Free DNase Set 
(Qiagen, Hilden, Germany). Reverse transcription was 
performed with Omniscript RT Kit (Qiagen). The mas-
termix was prepared as follows: 2  µl Buffer RT (10×), 
2  µl dNTP mix (5  mM each), 0,7  µl RNAse inhibitor 
(20 units/µl, Invitrogen via LifeTechnologies, Carlsbad, 
CA, USA), 0,2 µl Oligo-dT primer (10 µM, Qiagen) and 
1  µl Omniscript Reverse Transcriptase were mixed and 
RNase free water was added to a final volume of 10 µl. To 
test genomic DNA digestion success, we omitted reverse 
transcriptase and replaced it by RNase free water for one 
reaction. After addition of 1 µl RNA (200 µg/µl), we incu-
bated the reaction mix for 1 h at 37 °C. cDNA not directly 
used for further experiments was stored at −20  °C. 
Amplification of Ar was achieved with a matching primer 
pair for murine and rat Ar obtained from Eurofins MWG 
Operon (Huntsville, AL, USA) as can be seen in Table 7 
and Taq PCR Master Mix Kit (Qiagen). Mastermix was 
prepared as follows: 34 µl Taq PCR Master Mix, forward 
and reverse primer (2,5 µl each) and RNase free water as 
well as 1 µl cDNA were mixed to a final volume of 50 µl. 
Amplification was performed with 1× 94  °C for 4  min, 
35× (94 °C for 40 s, 60 °C for 45 s, 72 °C for 90 s) and 1× 
72 °C for 5 min.
As the prepubertal rat Sertoli cell line 93RS2 proved to 
be devoid of Ar, we chose this cell line for further experi-
ments. The cells were maintained in a 5  % CO2 atmos-
phere at 34  °C. The standard culture media consists of 
DMEM high glucose mixed 1:1 with Ham’s F-12 media 
plus 100 units/ml penicillin, 0,1  mg/ml streptomycin, 
10 % FBS-Gold (total protein 3.0–4.5 g/dl), and 1 % ITS 
(1000 mg/l Insulin, 550 mg/l Transferrin, 0.68 mg/l Sele-
nin). Unless otherwise stated, cell culture media were 
purchased from Invitrogen (via Life Technologies, Carls-
bad, CA, USA).
Ethics, consent and permissions
For positive control used in RT-PCR and Western Blot-
ting, we used testis homogenate from a patient show-
ing normal spermatogenesis attending the andological 
clinic in Münster for re-fertilization surgery. After writ-
ten informed consent, biopsies were taken under general 
anesthesia. The reported study has been approved by the 
Ethics committee of the Medical Faculty of the Justus 
Liebig University Giessen (decision 75/00 and 56/05).
AR transfection in 93RS2 Sertoli cells
We introduced a commercial available full length human 
AR (OriGene, Rockville, MD, USA), containing 17 CAG 
triplets, into the expression vector pcDNA 6.2 C-EmGFP 
(Invitrogen) after amplification of AR using GC-Rich 
PCR System (Roche, Basel, Switzerland), according to 
manufacturer’s instructions. Transfection of 93RS2 cells 
was performed using the microporation system MP-100 
(Peqlab). Cells were detached by Trypsin (PAA, Piscata-
way, NY, USA) and subsequently adjusted to 200,000 cells 
per well in a 6-well-plate. After re-suspending the cells in 
the provided buffer, plasmid DNA was added. We used a 
current strength of 1150 V for 20 ms with two pulses.
Validation of transfection success in 93RS2 
by immunofluorescence, RT‑PCR and Western Blotting
24  h after transfection, transfected cells (93RShAR17) 
were fixed in 6-well-plates with 4  % paraformaldehyde 
for 20  min at room temperature, washed three times 
with PBS and permeabilized with 0.1  % Triton x-100. 
After transferring the cells to a 12-well-plate and wash-
ing with PBS, unspecific binding sites were blocked with 
3 % BSA (bovine serum albumin, Carl Roth GmbH + Co.
KG, Karlsruhe, Germany) in TBST (Tris-Buffered Saline 
and Tween 20, Carl Roth) and washed again with PBS. 
The rabbit anti-GFP antibody (ab290, Abcam, Cam-
brigde, UK) was added in a dilution of 1:200. After incu-
bation for 3  h and washing with PBS, goat anti-rabbit 
Alexa 488 antibody (Invitrogen) was added in a dilution 
of 1:200. After a final incubation for 1 h in the dark, cells 
were washed and embedded with Vectashield mounting 
medium with DAPI (H-1200, Vector Laboratories, Dos-
senheim, Germany). Transfection efficiency was evalu-
ated using a fluorescence microscope (AxioPhot, Zeiss, 
Oberkochen, Germany). Western Blot analysis to prove 
antibody specificity and AR protein expression in trans-
fected Sertoli cells was performed as described else-
where [43]. Shortly, proteins extracted from cell lysates 
of transfected 93RS2 cells and human testis tissue were 
submitted to protein extraction using TRI Reagent® RNA 
Isolation Reagent (Sigma-Aldrich, St. Louis, MO, USA) 
according to Chomczynski [44]. Proteins were run on a 
3–8 % Tris–acetate gel (Life Technologies, Carlsbad, CA, 
USA) for 75 min at 150 V and blotted on nitrocellulose 
membrane for 75 min at 30 V. A polyclonal rabbit anti-
human AR antibody (sc-816, Santa Cruz Biotechnology 
Inc., Dallas, TX, USA) in a 1:500 dilution and a bioti-
nylated goat anti-rabbit antibody (E0432, Dako, Glostrup, 
Denmark) in a 1:1000 dilution were used. As weight 
marker, we used HiMark™ Pre-Stained Protein Stand-
ard (Life Technologies). Signal detection was performed 
by incubating the membrane with Vectastain Elite ABC 
Standard Kit (Vector Laboratories, Inc., Burlingame, CA, 
USA) and TrueBlue™ Peroxidase Substrate (KPL, Gaith-
ersburg, MD, USA). A negative control was performed by 
omitting the primary antibody.
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To detect AR mRNA in transfected cells, we performed 
RT-PCR (primers may be seen in Table  7) as described 
earlier with minor changes concerning the cycling con-
ditions: 1× 94  °C for 4  min, 35× (94  °C for 45  s, 55  °C 
for 45 s, 72 °C for 90 s) and 72 °C for 5 min resulting in 
a 591  bp amplicon. The CAG repeat length was con-
firmed using RT-PCR with subsequent high resolution 
polyacrylamide gel electrophoresis (PAGE) as described 
recently [45].
RNA isolation for microarray analysis
Total RNA of transfected 93RShAR17 cells as well as of 
non-transfected 93RS2 cells (using three technical rep-
licates (N1-N3) each) was extracted using the peqGold 
total RNA kit (Peqlab) following manufacturer’s instruc-
tions. The amount of RNA was measured on a BioPho-
tometer (Eppendorf, Hamburg, Germany) as follows: 
93RS2 N1 2200 ng/µl, N2 2130 ng/µl and N3 1920 ng/µl 
and 93RS2hAR17 N1 990  ng/µl, N2 1150  ng/µl and N3 
1065 ng/µl (each replicate with a total volume of 15 µl). 
RNA was stored after extraction until use at −80 °C and 
transported in liquid nitrogen. The quality of total RNA 
was checked on a 1 % agarose gel stained with ethidium 
bromide (Sigma-Aldrich) as well as on Agilent 2100 Bio-
analyzer using Eukaryote Total RNA Nano Assay (Agilent 
Technologies, Santa Clara, CA, USA). For this purpose, 
RNA was diluted to a concentration of 300  ng/µl. Only 
high quality RNA samples were used for microarray 
analysis.
Microarray analysis
cRNA synthesis and hybridization
Extracted RNA was transcribed into biotinylated cRNA 
using MessageAmp™ II-Biotin Enhanced Kit (LifeTech-
nologies). Biotinylated cRNA again was quality checked 
on Agilent 2100 Bioanalyzer as stated above followed by 
cRNA fragmentation and finally hybridization on Code-
Link Rat Whole Genome using the CodeLink Expression 
Assay Kit (GE Healthcare, Chalfont St. Giles, Bucking-
hamshire, UK). For this, 10  µg cRNA was diluted with 
nuclease-free water to final volume of 20  µl and mixed 
with 5  µl fragmentation buffer (taken from CodeLink 
iExpress iAmplify cRNA Prep & Hyb Kit, GE Healthcare) 
and fragmented at 94 °C for 20 min and subsequent cool-
ing to 0 °C on ice. Hybridization solution was prepared by 
mixing hybridization buffer component A and B (taken 
from CodeLink iExpress iAmplify cRNA Prep & Hyb 
Kit), nuclease-free water and 25  µl fragmented cRNA. 
Denaturation of cRNA was performed at 90 °C for 5 min 
with subsequent cooling on ice. Hybridization reaction 
was carried out at 37  °C for 18  h. Subsequent washing 
was performed with 0.75  ×  TNT (1  M Tris–HCl, 5  M 
NaCl and 20 % Tween 20) buffer. Bioarrays were stained 
with Cy5™-streptavadin (GE Healthcare) and scanned 
using the GenePix® 4000 B scanner and the GenePix Pro 
4.0 Software (Axon Instruments, Arlington, USA). Scan 
resolution was set to 5 microns. A total of 2 × 3 = 6 array 
images were subjected to data analysis. Spot signals of 
CodeLink bioarrays were quantified using the CodeLink 
System Software 5.0.0.31312 which generated local back-
ground corrected raw as well as median centred intra-
slide normalized data.
Quality control of microarray data
The genes represented by probe sets were annotated 
using the biocLite package (BioConductor) with the 
library “rwgcod.db” for CodeLink Rat Whole Genome 
arrays. The intra-slide normalized data containing 35129 
rows and 6 columns (200  k values) were processed by 
an automated workflow that includes omission of con-
trol genes (n  =  1280), removal of genes with poor QC 
(n = 1300 values, 0.6 %) or negative sign (n = 1603 val-
ues, 0.8 %), removal of probe sets with too high propor-
tion (≥50 %) of missing values per group (n = 203 probe 
sets, 0.5  %) or with not any group having at least 50  % 
of values flagged as “G =  good” and 50  % values above 
threshold (n = 7177 probe sets, 21.2 %), removal of out-
liers (expression values deviating more than fourfold 
from the group median, n =  427 values, 0.3 %). A total 
of 26452 probe sets remained after quality control with 
1257 probe sets (=4.7 %) containing 1235 missing values 
(=0.8 %).
Remaining missing values were imputed by proba-
bilistic principal component analysis (PPCA) using the 
R-package pca Methods. Imputed dataset was quantile 
normalized using the R-package limma [46], and loga-
rithm for the base 2 was calculated.
Differential gene expression
Students t test was applied and a false discovery rate 
(FDR) ≤0.01 was set for the significance level with an 
absolute fold change (FC) ≥2 between transfected and 
non-transfected cells.
Functional gene analysis: overrepresentation analysis
Enriched functional gene ontology (GO) categories 
within the differentially regulated genes were determined 
using DAVID version 6.7 [47, 48]. Functional annotation 
clustering as well as an enrichment score was calculated 
for each cluster.
Upstream regulation analysis
To identify the regulators responsible for the observed 
gene expression profiles, we performed prediction 
analysis for activation or inhibition of upstream regu-
lators using the Ingenuity® Pathway Analyzer and the 
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Table 7 Primer sequences
Primer name GenBank accession no. Sequence (5′ ≥ 3′) Amplicon  
length (bp)
RT‑qPCR  
efficiency (%)
Ar NM_013476 For CACATCCTGCTCAAGGCGCTT 181 n.a.
(mouse) Rev CCCAGAAAGGATCTTGGGCAC
NM_012502 181 n.a.
(rat)
AR NM_000044 For TATCCCAGTCCCACTTGTG 592 n.a.
Rev TCTCTCCCAGTTCATTGAGG
Aldh1a2 NM_053896 For TCAGACTTCGGGCTTGTAGC 125 94.3
Rev GGGCTCTGAGCATTTAAGGC
Apoe NM_001270681 For TGATGGAGGACACTATGACG 188 105.8
Rev CATGGTGTTTACCTCGTTGC
Bambi NM_139082 For CCATGCCCACTTTGGAATGC 126 128.0
Rev TTCTGCTGCTGTCATGCTGG
Cdkn1a NM_080782 For CACAGGAGCAAAGTATGCCG 125 135.1
Rev GCGAAGTCAAAGTTCCACCG
Col4a1 NM_0011350009 For GGAGAACCTGGCAGTGATG 118 99.9
Rev CACCCTTGGAACCTTTGTC
Dhh NM_053367 For TTGGCACTCCTGGCACTATC 124 102.2
Rev CGGGCATACTAGGCACAAAC
Egr1 NM_012551 For GTGGGAGAAAGTTTGCCAGG 125 111.3
Rev GTAGGAAGAGAGGGAAGAGG
Fgfr2 NM_012712 For CAGCTTCCCCAGATTACCTG 92 94.4
Rev CATTCGGCAAAAGATGACTG
Fst NM_012561 For TCCAGTACCAGGGCAAATG 78 96.2
Rev TCTGATCCACCACACAAGTG
Gja1 NM_012567 For GTACGGGATTGAAGAGCACG 119 105.5
Rev TGTACCACTGGATGAGCAGG
Hsd17b10 NM_031682 For GAGGAAACTGCATATTTGCC 106 110.5
Rev TTGACAGCCACATCTATACG
Inhbb NM_080771 Rev ACGGGTCAAGGTGTACTTCC 96 100.3
For AAGGTATGCCAGCCACTACG
Myc NM_0123603 Rev TACATCCTGTCCGTTCAAGC 67 108.0
For GCCGTTTCCTCAGTAAGTCC
Ncam1 NM_031521 Rev ACGATGATGACTCCTCTACC 150 94.1
For GCGCATTCTTGAACATGAGC
Pmepa1 NM_001107807 Rev TGGTGATGGTGGTGATGATC 76 134.2
For CTGTGTCGGCTGATGAAGG
Ptsg2 NM_017232 Rev ACCGTGGTGAATGTATGAGC 104 98.4
For TCTTGTCAGAAACTCAGGCG
Rarg NM_001135249 Rev TCACCAAGGTCAGCAAAGCC 125 141.9
For ACTGAACTTGTCCCACAGCC
Rbp1 NM_012733 Rev CTTCAGTGTGTTCAGAAGGG 117 87.9
For CTTGAACACTTGCTTGCAGG
Rplp2 NM_001030021 Rev TTGCCTCTTATCTGCTGGCC 110 103.4
For GTTGAGTCGTTCATCGTCCG
Sulf2 NM_001034927 Rev TTCCTGCCCAAGTATCAGC 108 111.5
For CCCAGAAGCGTCCTCTACAC
Tf NM_001013110 Rev TGAGGTCTTGCCACAGAAGG 125 102.4
For CCACAACAGCATGAGAAGGG
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Ingenuity®Knowledge Base (IPA, Qiagen). Prediction is 
given as a z-score with >2 for activated and <2 for inacti-
vated upstream regulators.
Validation of microarray results by quantitative RT‑PCR 
(RT‑qPCR)
For validation of microarray data, we performed RT-
qPCR with 93RShAR17 and non-transfected 93RS2 
cells for 22 genes (Table  7) that have been shown to be 
significantly altered in microarray analysis. All primer 
pairs obtained from MWG Operon have been validated 
in standard RT-PCR using rat testis as positive control. 
For this pupose, total RNA from rat testis was extracted 
using TRI Reagent® RNA Isolation Reagent (Sigma-
Aldrich) according to Chomczynski [44]. Genomic 
DNA was digested by using DNase I (Roche). For this, 
6,65 µl RNA (200 ng/µl) were incubated with 1 µl MgCl2 
(25  mM, Thermo Fisher Scientific), 1  µl DNase Buffer 
(Roche), 0,25  µl RNase inhibitor (40 units/µl, Thermo 
Fisher Scientific) and 1 µl DNase I for 25 min at 37 °C in a 
thermocycler. After a enzyme heat inactivation for 5 min 
at 75 °C, RNA was immediately reversely transcribed into 
cDNA. For this, 1,5  µl DNase-treated RNA was mixed 
with 1 µl 10x PCR Gold Buffer, 2 µl MgCl2 (25 mM), 1 µl 
dNTP mix (each 2,5 mM), 0,5 µl random hexamer primer 
(50 mM), 0,5 µl RNase inhibitor (20 units/µl), 0,5 µl Mul-
tiScribe® Reverse Transcriptase (50 units/µl) and RNase 
free water to a final volume of 9  µl. All reagents were 
obtained from Thermo Fisher Scientific. For -RT control, 
reverse transcriptase was replaced by the same amount of 
RNase free water. Incubation was performed as follows: 
8 min at 21 °C, 15 min at 42 °C and 5 min at 99 °C. cDNA 
was stored at −20 °C until use. For primer validation in 
standard RT-PCR, 1 µl cDNA was mixed with 2,5 µl 10× 
PCR Gold Buffer, 2 µl MgCl2 (25 mM), dNTP mix (each 
2.5  mM), 1  µl forward and reverse primer, respectively 
(each 10 pM), 0.125 µl AmpliTaq Gold® DNA Polymer-
ase (5 units/µl) and RNase free water to a final volume of 
25 µl. Cycling conditions were: 1× 94 °C for 9 min, 35× 
(94 °C for 45 s, 60 °C for 45 s, 72 °C for 45 s) and 72 °C 
for 5 min. Length of the resulting amplicons was checked 
in an agarose gel electrophoresis as described earlier. For 
RT-qPCR dilution series we used rat Rplp and Ubc as 
internal reference genes and performed triple determina-
tion in a decreasing 10- fold dilution series (undil., 1:10, 
1:100). RT-qPCR efficiency (E) has been calculated using 
Bio-Rad CFX Manager version 3.1 (Bio-Rad) from the 
standard curve’s slope and may be seen in Table 7. Ref-
erence genes have been determined by using a TaqMan® 
Array Rat Endogenous Control Plate (96-well, 32 refer-
ence genes pre-plated, Applied Biosystems via Thermo 
Fisher Scientific, Waltham, MA, USA).
For RT-qPCR, total RNA from transfected and non-
transfected cells was extracted using peqGold Total RNA 
Kit (PEQlab) and reversely transcribed into cDNA as 
described above. As technical replicates we used cell pel-
lets from three independent passages and for each speci-
men, double determination was performed using 1  µl 
of cDNA, 4 µl EvaGreen mastermix (no Rox) (Bio&Sell, 
Feucht, Germany), 0.6  µl forward and reverse primer 
each and 12.8 µl sterile aqua bidest to a final volume of 
20  µl. RT-qPCR conditions were 1× 95  °C for 15  min, 
40× (95 °C for 15 s, 60 °C for 30 s, 72 °C for 20 s) followed 
by melt curve analysis (1× 95 °C for 10 s, 65 °C to 95 °C, 
increment 0.5  °C for 5  s) on a CFX96 RealTime cycler 
(Bio-Rad Laboratories, Hercules, CA, USA). Relative 
gene expression was calculated by the 2−ΔΔCq method, 
using Rplp and Ubc as internal reference genes. Expres-
sion levels represent x fold higher expression in the trans-
fected than in the non-transfected cells (set as “1”). For 
statistical analysis, differences of the mean were assessed 
by ANOVA analysis. P-values of p ≤ 0.05 are set as statis-
tically significant. The Cq values for all transcripts may be 
seen in Additional file 1: Table S1.
Availability of supporting data
Complete microarray data may be found on GEO 
Accession Viewer database [19] with accession num-
ber GSE57653. Single Sertoli cell line data may be found 
under accession numbers GSM1385418 (Sertoli Cell 
Sequence and RT-qPCR efficiency of primers used for the study
n.a. not applied
Table 7 continued
Primer name GenBank accession no. Sequence (5′ ≥ 3′) Amplicon  
length (bp)
RT‑qPCR  
efficiency (%)
Tgfb1i1 NM_001191840 Rev ACTACATCTCGGCACTCAGC 101 106.5
For ACCCTCGTGCTCAAAGAAGC
Tnfrsf1a NM_013091 Rev AAAGAGGTGGAGGGTGAAGG 128 101.7
For ACAGGATGACTGAAGCGTGG
Ubc NM_017314 Rev GGCAAAGATCCAGGACAAGG 100 99.4
For TTGTAGTCTGACAGGGTGCG
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Line noAR_1), GSM1385419 (Sertoli Cell Line noAR_2), 
GSM1386001 (Sertoli Cell Line noAR_3), GSM1385420 
(Sertoli Cell Line AR17_1), GSM1385421 (Sertoli Cell 
Line AR17_2), GSM1385422 (Sertoli Cell Line AR17_3). 
Raw data of RT-qPCR experiments can be seen in Addi-
tional file 1: Table S1.
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